|
|
||||||||
Departments of 1 Psychology and 3 Zoology and 2 Neuroscience Program, Michigan State University, East Lansing, Michigan 48824-1117
| |
ABSTRACT |
|---|
|
|
|---|
Most mammals show daily rhythms in sleep and wakefulness controlled by the primary circadian pacemaker, the suprachiasmatic nucleus (SCN). Regardless of whether a species is diurnal or nocturnal, neural activity in the SCN and expression of the immediate-early gene product Fos increases during the light phase of the cycle. This study investigated daily patterns of Fos expression in brain areas outside the SCN in the diurnal rodent Arvicanthis niloticus. We specifically focused on regions related to sleep and arousal in animals kept on a 12:12-h light-dark cycle and killed at 1 and 5 h after both lights-on and lights-off. The ventrolateral preoptic area (VLPO), which contained cells immunopositive for galanin, showed a rhythm in Fos expression with a peak at zeitgeber time (ZT) 17 (with lights-on at ZT 0). Fos expression in the paraventricular thalamic nucleus (PVT) increased during the morning (ZT 1) but not the evening activity peak of these animals. No rhythm in Fos expression was found in the centromedial thalamic nucleus (CMT), but Fos expression in the CMT and PVT was positively correlated. A rhythm in Fos expression in the ventral tuberomammillary nucleus (VTM) was 180° out of phase with the rhythm in the VLPO. Furthermore, Fos production in histamine-immunoreactive neurons of the VTM cells increased at the light-dark transitions when A. niloticus show peaks of activity. The difference in the timing of the sleep-wake cycle in diurnal and nocturnal mammals may be due to changes in the daily pattern of activity in brain regions important in sleep and wakefulness such as the VLPO and the VTM.
ventrolateral preoptic area; sleep; suprachiasmatic nucleus; galanin; histamine
| |
INTRODUCTION |
|---|
|
|
|---|
THE SUPRACHIASMATIC NUCLEUS (SCN), the primary circadian pacemaker in mammals, is critical for the expression of circadian rhythms in physiology and behavior (12). Although physiological and behavioral variables follow predictable circadian patterns, animals differ in how their daily activity relates to the light-dark cycle; namely, some animals are active during the dark phase (nocturnal) and some are active during the light phase (diurnal). Little is known about the differences between neural structures controlling the circadian systems of diurnal and nocturnal species, and much of what we know about circadian physiology comes from studies using only nocturnal rodents.
Although species differences exist in how light pulses affect the SCN of nocturnal and diurnal animals (13, 24), other observations have identified similarities in SCN function across species that show very different activity patterns with respect to the light-dark cycle. For example, taken as a whole, the SCN is metabolically more active during the light phase of the cycle in both nocturnal and diurnal mammals (29, 30; but see Ref. 25). Similarly, when animals are kept on a 12:12-h light-dark cycle, the pattern of Fos protein expression in the SCN of a diurnal rodent Arvicanthis niloticus (Nile grass rat) is similar to that seen in the rat (10, 21). In both species, Fos immunoreactivity is high in the light and low during darkness (21). Last, the SCN neuronal firing rates peak in the light phase regardless of the phase in which the animals are active (9, 14, 26, 39). Given these common features, it is possible that differences in the phase of behavioral rhythms across species result from the differential responsiveness of SCN targets to clock signals received via axonal and/or humoral outputs of the SCN (34, 37, 38).
In rats, forebrain regions important in sleep and wakefulness show rhythms in Fos expression over a 12:12-h light-dark cycle (19). These rhythms are predictable from the daily activity pattern of these nocturnal rodents. In the ventrolateral preoptic area (VLPO), a brain region important in slow-wave sleep initiation and maintenance (33, 36), Fos expression increases in the middle of the light phase, at the time when these animals sleep. A mechanism through which the VLPO is believed to induce sleep is via the inhibition of monoaminergic brain regions important in arousal, through the actions of GABA and galanin (Gal); one such region is the histaminergic tuberomammillary nucleus (TMN) of the posterior hypothalamus (32, 33, 35).
In rats, the rhythms in Fos expression are 180° out of phase in the VLPO relative to both the rhythms seen in the paraventricular thalamic nucleus (PVT) and centromedial thalamic nucleus (CMT) (19). Fos expression in these nuclei increases during the night when rats are active and show less sleep. These rhythms in Fos expression are also predictable from the activity patterns of these animals, because neural activity in the CMT and PVT increases during behavioral arousal and vigilance (1, 3, 5, 6, 8, 11, 23, 31).
The difference between the sleep-wake cycles of diurnal and nocturnal animals is presumably associated with a change in the phase of the daily patterns of neural activity in brain areas that control sleep and wakefulness. Recent observations support that claim. Thus, using the diurnal murid rodent A. niloticus, we demonstrated an increase in Fos expression in the VLPO that coincided with the display of behavioral correlates of sleep in that species (20). This elevation in Fos expression was seen 8 h into the dark phase of a 12:12-h light-dark cycle, a time associated with low levels of Fos production in the VLPO of the nocturnal rat (19). Different from rats, A. niloticus sleep during the dark phase of the illumination cycle and are awake during the day and also awake and active at dawn and dusk (10, 20).
In this study, we present data on some anatomic features of the sleep-active area of the VLPO of A. niloticus. We also report on the patterns of Fos expression in the VLPO of this diurnal rodent across the light-dark cycle. Finally, we compare the patterns seen in the VLPO with those of brain regions involved in the support of wakefulness (i.e., the PVT, CMT, and TMN).
| |
METHODS |
|---|
|
|
|---|
Experiment 1: Anatomic Features of the VLPO of A. niloticus
Animals. The A. niloticus used in these experiments were born in the laboratory and were descended from a group of animals trapped in Kenya in 1993. Animals were group housed (2-5 per box, in clear polycarbonate cages, 35.7 × 3 × 17 cm) under a 12:12-h light-dark cycle, with lights on at zeitgeber time (ZT) 0; a dim red light was on all the time. Animals were fed and watered ad libitum with Harlan 8640 Teklad 2215 rodent diet and tap water. Two female A. niloticus were used in the first experiment.Galanin immunostaining. Two female A. niloticus were
injected with Nembutal (pentobarbital sodium, Abbott Laboratories; 0.9 ml/kg ip) and placed in a stereotaxic device (Stoelting), and a local
anesthetic was given under the skin of the head (0.01 ml 2% lidocaine,
1:1 with saline, Elkins-Sinn). Two holes were drilled in the skull
using a dental drill, and colchicine (5 µl volume, 0.0025 mg; Sigma)
was injected bilaterally into the lateral ventricles to block axonal
transport to facilitate the detection of Gal in cell bodies. The
following coordinates were used: anteroposterior +1.0 from bregma,
mediolateral ±2.3, dorsoventral
4.3 from skull, with the bite
bar set at
5.0. The injection was made over a 5 min
period using a 10-µl Hamilton syringe; the syringe was removed 5 min
after completion of the injection. Each animal was then removed from
the stereotaxic apparatus, and the wound was closed using autoclips and
treated with Novalsan antiseptic ointment (Fort Dodge
Laboratories). The animals received 1 ml saline and 0.3 ml sc Buprenex
(10% in saline; Bergen Brunswic) and placed on a heating pad for
postsurgical recovery. After surgery, the animals were individually housed.
Twenty-four hours after surgery, the animals were injected with 0.5 ml Nembutal and perfused transcardially with 125 ml 0.01 M PBS, followed by 125 ml 4% paraformaldehyde mixed with 0.2% sodium periodate and 1.3% lysine in PBS (PLP). Brains were removed, postfixed for 4 h, allowed to saturate in a 20% sucrose solution (in 0.1 M PBS), and sectioned into three sets of 30 µm frozen sections that were stored in cryoprotectant for later use.
One set of sections (every 3rd section) was processed using immunocytochemistry (ICC) for Gal. Sections were rinsed for 1 h in 0.01 M PBS before incubation in the primary antiserum, rabbit anti-Gal (Cambridge), at a 1:10,000 dilution in 5% normal goat serum (NGS) and 3% Triton X-100 (tx) for 18 h at 4°C. Sections were then rinsed and incubated in the secondary antiserum (biotinylated goat anti-rabbit, 1:200; Vector Laboratories) in PBS-tx. Tissue was then placed in the avidin-biotin complex (Vector Laboratories). Sections were then reacted with 3,3'-diaminobenzidine with 0.3% hydrogen peroxide for 2 min, then rinsed, mounted onto gelatin-coated slides, placed under a coverslip, and observed under the microscope. An optical grid (190 µm2) was placed over the VLPO, and Gal+ cells within this area were counted on each side of the brain in four sections at ×400 magnification using a Zeiss microscope. The number of Gal+ cells in each VLPO (unilateral) was averaged across sections. Additionally, preabsorbtion with Gal peptide (Sigma; 50 µg Gal peptide in 500 µl PBS, with 5 µl anti-Gal primary antibody) and deletion of the primary antiserum for Gal both resulted in tissue devoid of immunostaining.
Experiment 2: Daily Rhythms of Fos Expression in the Forebrain of A. niloticus
Animals and tissue collection. Twenty-four male A. niloticus housed on a 12:12-h light-dark cycle were used in this experiment. Animals were singly housed and fed and watered ad libitum as described above.The animals were perfused in pairs at four ZTs: ZT 1, ZT 5, ZT 13, and ZT 17 after an injection of equithesin (1 ml ip). At ZT 13 and 17, a light-tight hood was placed over the animals' heads to prevent light-induced Fos expression. The animals were then perfused with PBS and PLP as described earlier. Brains were postfixed for 24 h and then transferred to 20% sucrose in PBS. The brains were sectioned into three sets at 30 µm using a freezing microtome and the sections were stored in cryoprotectant.
Fos and histamine immunostaining. Every third section was processed for Fos ICC using a rabbit anti-Fos primary antibody (Santa Cruz). Separately, the posterior half of the hypothalamus was subjected to double-labeled ICC for Fos and histamine. The standard protocol (described above) was used with some modifications. For Fos, the primary antiserum used was sheep anti-Fos (Cambridge, 1:1,000) with normal donkey serum, the secondary antiserum was donkey anti-sheep (1:200, Vector Laboratories), and DAB with nickel intensification was the chromagen. For histamine ICC, rabbit antihistamine (Sigma, 1:1,000) was used with NGS; the secondary antiserum was goat anti-rabbit, and DAB was the chromagen (3-min incubation for each chromagen). No immunostaining for histamine was detected after primary antibody deletion or preabsorbtion with histamine (100 µg/ml diluted serum; Sigma).
Analysis. The number of Fos-immunoreactive (Fos+) cells in the VLPO was counted at ×400 magnification using a 190 µm2 optical grid (20). The PVT, CMT, and TMN were identified with the aid of the rat brain atlas (22). The PVT was divided into anterior, middle, and posterior using the landmarks described in Peng et al. (23): the anterior PVT was bounded by the stria medularis and the third ventricle dorsally; the middle and posterior PVT were located ventral to the habenula; the posterior PVT was also more distinctly bilateral (2 nuclei as opposed to 1 midline nucleus) than the middle PVT. The number of Fos+ cells was determined for each region at ×250 magnification. The number of Fos+ cells in the CMT was determined at ×250 magnification using an optical grid (300 µm2).
Two subdivisions of the TMN were examined for Fos expression (7, 22). The dorsal TMN (DTM) was located in the posterior hypothalamus, on either side of the third ventricle; the number of Fos+ cells in one section containing the DTM was counted at ×100 in an area of 120 µm2. The ventral TMN (VTM) was located caudal to the DTM, along the edge of the brain bilaterally in the posterior hypothalamus; the number of Fos+ cells in a 150 µm2 grid was counted at ×250. This grid encompassed the magnocellular region of the VTM, the size of which differed from the size of the DTM.
The data (number of Fos+ cells) for each brain region were used to obtain the average number of Fos+ cells per section. For each brain region, one-way ANOVAs were used for data analysis, with the number of Fos+ cells per section as the dependent variable and the ZT as the independent variable; Fisher's protected least significant difference (PLSD) test was used for pairwise comparisons. Correlations between brain regions with respect to the number of Fos+ cells per section were also determined using Pearson's r. Differences and correlations were considered significant if P < 0.05.
For the histamine double-labeled ICC, the number of histamine-immunopositive (Hist+) cells as well as the number of Hist+ cells containing Fos were counted in the lateral group of Hist+ cells (including but not confined to the area used to count Fos+ cells in the VTM described above) using an Olympus BX 60 microscope at ×400. The percent of Hist+ cells containing Fos was calculated for each animal. Because the data were expressed as percentages, they were subjected to an arc sin transformation to normalize the distribution. The data were then subjected to a one-way ANOVA, with ZT as the independent variable and percent Hist+ cells containing Fos as the dependent variable; Fisher's PLSD tests were used for pairwise analyses.
| |
RESULTS |
|---|
|
|
|---|
Experiment 1
Gal. As shown in Fig. 1, many Gal+ cells were found in the area identified as the VLPO in A. niloticus. The location of the cluster (Fig. 1) is similar to that described in rats (32). This area is found just dorsal to the lateral edge of the optic chiasm and medial to the nucleus of the horizontal limb of the diagonal band, with the caudal end of the VLPO in the same section as the rostral pole of the SCN. The cluster of cells is pyramidal in shape, with the base near the edge of the optic chiasm and flaring out dorsally and laterally. In the set of sections processed for Gal-ICC (every 3rd section), a mean of 34.63 (SE = 3.63) Gal+ cells per section (unilateral) was found in the VLPO. Gal+ cells were concentrated in a cluster in the VLPO, with scattered Gal+ cells in the preoptic area (Fig. 2). Cells heavily labeled for Gal were also seen in the paraventricular hypothalamic nucleus and supraoptic nucleus (data not shown), regions where Gal+ cell bodies have previously been described in the rat (16, 17).
|
|
Experiment 2
As shown in Fig. 3, ZT significantly affected the number of Fos+ cells in the VLPO (F3,20 = 3.486, P < 0.05). The number of Fos+ cells at ZT 17 was significantly greater than the number at ZT 5 and ZT 13 (P < 0.05; see Fig. 4). As shown in Fig. 5, Fos+ cell number also varied significantly across time of day in the PVT (F3,20 = 8.439, P < 0.001; see Fig. 6). There were more Fos+ cells in the PVT at ZT 1 than at any other time point (P < 0.05); also, more Fos+ cells were found in the PVT at ZT 5 than at ZT 13 (P < 0.05). When the PVT subregions were analyzed, a significant rhythm of Fos expression was found in the middle PVT (F3,20 = 4.605, P < 0.05) and posterior PVT (F3,20 = 7.861, P < 0.01), but not in the anterior PVT (F3,20 = 1.782, P = 0.183). The daily patterns in Fos expression were similar in each PVT subdivision; the data for the PVT subdivisions were pooled, and the data on Fos expression for the entire PVT Fos expression were used for the correlational analyses (see below).
|
|
|
|
No significant differences in Fos+ cell number across the light-dark
cycle were found in the CMT (F3,20 = 1.251, P = 0.318; see Fig. 5). However, as illustrated in Fig.
7, a highly significant correlation was
found between Fos+ cell number in the PVT and the CMT (r = 0.794, P < 0.0001). A significant rhythm in the number of
Fos+ cells was found in the VTM (F3,20 = 4.330, P < 0.05), where Fos cell number at ZT 17 was less
than any other time point (P < 0.05; see Figs.
8 and 9). No
effect of ZT was found in the DTM (F3,19 = 0.646, P = 0.595). Fos+ cell numbers in the CMT were also
positively correlated with those for the VTM (r = 0.414, P < 0.05).
|
|
|
As shown in Fig. 10, some Hist+ cells in
and around the VTM contained Fos immunoreactivity. There was a
significant rhythm in Fos expression within Hist+ cells of the VTM
(F3,18 = 5.965, P < 0.01). Specifically,
more Hist+ cells contained Fos at both ZT 1 and ZT 13 than at ZT 17 and
more double labeling was seen at ZT 13 than at ZT 5 (P < 0.05; see Fig. 11).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The location of the VLPO of A. niloticus is similar to that described for the rat (20, 32, 33). It is comprised of a cluster of cells adjacent to the nucleus of the horizontal limb of the diagonal band in the lateral preoptic area. Furthermore, as in the rat (32), neurons of this area are Gal+. Together with data showing that Fos expression in the VLPO increases at times when these animals sleep (19), these findings suggest that the VLPO serves a similar function in nocturnal rats and in the diurnal A. niloticus.
The results showed that the VLPO of the diurnal A. niloticus displays a daily rhythm in Fos expression in animals kept in a 12:12-h light-dark cycle. Fos+ cell number increased in the middle of the night at ZT 17. Observations of behavioral indexes of sleep showed that A. niloticus are most likely to be sleeping in the middle of the dark phase and least likely to be sleeping at the light-dark transitions and during the light phase (20). The pattern of Fos expression seen in the VLPO of A. niloticus is, therefore, correlated with these animals' sleep patterns: at ZT 17, when VLPO Fos expression is high, grass rats are likely to be sleeping, whereas they are unlikely to be sleeping when VLPO Fos expression is low, at ZT 1-ZT 13. Taken together with previous data (20), these results indicate that VLPO Fos expression increases throughout the middle and late night in A. niloticus and decreases just before lights-on. The presence of a rhythm in the VLPO raises the possibility that the SCN may directly or indirectly influence the activity of the VLPO. Given the presence of very few direct projections from the SCN to the VLPO in rats (4, 18), this circadian regulation may be imposed via relay sites or via humoral rather than axonal SCN outputs (34).
This study also showed that the PVT of A. niloticus displays a daily rhythm in Fos expression. For the most part, the pattern seen in the PVT is predictable from the activity pattern of this species: at the time of the morning activity bout of these animals (ZT 1), Fos expression is highest in the PVT. The pattern seen during the dark phase, however, does not match expectations: Fos expression in the PVT does not increase at ZT 13, after these animals show a moderate activity peak, and it does not decrease at ZT 17, when they are likely to be sleeping and when Fos expression is elevated in the VLPO. These observations raise the possibility that the PVT is more important in maintaining wakefulness early in the light phase than during the rest of the cycle. In this diurnal species, other brain regions may be responsible for inducing wakefulness later in the day.
Although no rhythm was found in the DTM in A. niloticus, a significant rhythm in Fos expression was seen in the VTM, the region of the TMN shown to receive GABAergic and galaninergic projections from the VLPO in rats (32). Fewer Fos+ cells were found in the VTM of A. niloticus taken at ZT 17 than at any other time point. A. niloticus are most likely to be sleeping in the middle of the night (20), when VTM Fos expression is lowest. This pattern is the opposite of that seen in the VLPO, where Fos+ cell number was increased at ZT 17; given that the VTM and VLPO have mutually inhibitory connections (32), the decrease in Fos expression in the VTM at ZT 17 is not surprising. Because no rhythm in Fos expression was found in the rat TMN (unpublished data), the circadian modulation of Fos expression in the grass rat VTM may represent a species difference in the mechanism through which the circadian clock controls the activity cycle. The reduction in Fos expression in the VTM in A. niloticus seen during the middle of the night (ZT 17) may reflect a circadian signal to the TMN in A. niloticus that is weak or absent in rats. Reduced activity in the TMN may facilitate the display of sleep in this diurnal species.
The importance of histamine in the peaks of locomotor activity in grass rats is supported by data from this experiment showing that Fos expression in histaminergic cells within the VTM peaks at ZT 1 and ZT 13. Therefore, histaminergic cells are most active at the times of the day when this species shows the strongest activity, at the light-dark transitions (10, 20). This may contribute to the crepuscular nature of the A. niloticus activity pattern. Furthermore, because Fos expression in Hist+ cells did not significantly decrease from ZT 1 to ZT 5 in grass rats, histamine may also promote wakefulness during the daytime and therefore contribute to the diurnal portion of its activity cycle.
No significant rhythm in Fos expression was found in the CMT of A. niloticus, which suggests that there is a stronger circadian modulation of the VTM and PVT than the CMT in this species. This is in contrast to the significant pattern of Fos expression seen in the rat CMT and represents further evidence that wakefulness is supported by different brain arousal systems in the two species. Although no rhythm was seen in the CMT of A. niloticus, a significant positive correlation was seen between Fos expression in the PVT and CMT. Similar to the rat, because the PVT and CMT are activated together in A. niloticus, this correlation supports the assertion that these two brain regions contribute to wakefulness. Additionally, there was a significant correlation between Fos expression in the CMT and VTM. Both the activity of intralaminar nuclei and histamine release in the cortex are associated with desynchronization of the electroencephalogram (8, 28). Together, the activity of the CMT, PVT, and histaminergic nuclei may account for different components of arousal and wakefulness in this species.
Finally, the possible effects of light on Fos expression in the VLPO must be taken into account when evaluating the data from these two species. For example, the presence of significant retinal projections to VLPO in the rat (15), nearly absent in A. niloticus (20), implies that light may directly stimulate activity of the VLPO to contribute to its rhythmic expression of Fos in rats, but not in A. niloticus. In rats, but not diurnal chipmunks, the light-dark cycle has a powerful effect on daily activity even after SCN lesions (2, 27). The present findings suggest that this effect of light may be absent or diminished in the diurnal rodent examined here.
In summary, both nocturnal rats and diurnal A. niloticus show rhythms in brain areas affecting sleep and wakefulness, and these rhythms differ between the two species in ways that often mirror their activity patterns. Furthermore, species differences may extend to the differential involvement of brain arousal systems in the control of wakefulness and on the direct effects of light in the daily control of sleep patterns.
Perspectives
As observed in hypothalamic targets of the SCN (21), the daily pattern of Fos expression seen in the A. niloticus VLPO differs considerably from that seen in the rat VLPO (i.e., increased Fos production at ZT 5 and ZT 13). For the VLPO, there are several possible explanations for the species difference in the circadian control of Fos expression. The critical difference may lie in 1) a different circadian signal emanating from the SCN, such as a different neurotransmitter; 2) the same signal emitted at a different phase, in which case subpopulations of SCN cells that affect the VLPO would be expected to have different patterns of activity over the circadian cycle in the two species; and/or 3) there may be a species-specific alteration of the circadian signal by an intermediary brain region. Finally, 4), there may be differential responsiveness of the VLPO and other targets of the SCN to similar circadian signals. If this were the case, then the process of modifying the timing of activity of a mammalian species over evolution (i.e., from nocturnal to diurnal, after a nocturnal bottleneck) would have involved a change in responsiveness of various SCN target regions to a common signal.When the combined patterns of Fos expression in the PVT and VTM are considered, it is possible that, in A. niloticus, these two brain regions contribute in distinct but complementary ways to the overall activity pattern of these animals. This introduces a possible difference between diurnal and nocturnal animals not previously considered: that species differences in activity patterns may involve differential contributions of distinct arousal systems to overall activity and that the strength of circadian modulation (along with the daily pattern of circadian modulation) of these arousal systems differs between species. Additional work is needed to establish causal links between species differences in patterns of neural Fos expression and species differences in the distribution of sleep and wakefulness across the day-night cycle.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Julie Harris and Megan Mahoney for assistance on this project.
| |
FOOTNOTES |
|---|
This work was supported by National Institute of Mental Health (NIMH) Grant MH-1232 to C. M. Novak, National Science Foundation Grant IBN-9514374 to A. A. Nunez, and NIMH Grant MH-53433 to L. Smale.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: A. Nunez, Dept. of Psychology, Michigan State Univ., East Lansing, MI 48824-1117 (E-mail: nunez{at}pilot.msu.edu).
Received 27 September 1999; accepted in final form 2 December 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Allingham, K,
von Saldern C,
Brennan PA,
Distel H,
and
Hudson R.
Endogenous expression of c-Fos in hypothalamic nuclei of neonatal rabbits coincides with their circadian pattern of suckling-associated arousal.
Brain Res
783:
210-218,
1998[ISI][Medline].
2.
Boer, GJ,
Griffioen HA,
Duindam H,
van der Woude TP,
and
Rietveld WJ.
Light/dark-induced effects on behavioral rhythms in suprachiasmatic nucleus-lesioned rats irrespective of the presence of functional suprachiasmatic nucleus brain implants.
J Interdiscip Cycle Res
24:
118-136,
1993.
3.
Chastrette, N,
Pfaff DW,
and
Gibbs RB.
Effects of daytime and nighttime stress on Fos-like immunoreactivity in the paraventricular nucleus of the hypothalamus, the habenula, and the posterior paraventricular nucleus of the thalamus.
Brain Res
563:
339-344,
1991[ISI][Medline].
4.
Chou, TC,
Scammell T,
and
Saper CB.
Afferents to the ventrolateral preoptic nucleus.
Soc Neurosci Abstr
664.5:
1694,
1998.
5.
Cullinan, WE,
Herman JP,
Battaglia DF,
Akil H,
and
Watson SJ.
Pattern and time course of immediate early gene expression in rat brain following acute stress.
Neuroscience
64:
477-505,
1995[ISI][Medline].
6.
Duncan, GE,
Knapp DJ,
and
Breese GR.
Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety.
Brain Res
713:
79-91,
1996[ISI][Medline].
7.
Ericson, H,
Watanabe T,
and
Kohler C.
Morphological analysis of the tuberomammillary nuclei in the rat brain: delineation of subgroups with antibody against L-histidine decarboxylase as a marker.
J Comp Neurol
263:
1-24,
1987[ISI][Medline].
8.
Glenn, LL,
and
Steriade M.
Discharge rate and excitability of cortically projecting intralaminar neurons during waking and sleep states.
J Neurosci
2:
1387-1404,
1982[Abstract].
9.
Inouye, ST,
and
Kawamura H.
Characteristics of a circadian pacemaker in the suprachiasmatic nucleus.
J Comp Physiol [A]
146:
153-160,
1982.
10.
Katona, C,
and
Smale L.
Wheel-running rhythms in Arvicanthis niloticus.
Physiol Behav
61:
365-372,
1997[Medline].
11.
Kinomura, S,
Larsson J,
Guláa B,
and
Roland PE.
Activation by attention of the human reticular formation and thalamic intralaminar nuclei.
Science
271:
512-515,
1996[Abstract].
12.
Klein, DC,
Moore RY,
and
Reppert SM.
Suprachiasmatic Nucleus: The Mind's Clock. New York: Oxford University Press, 1991.
13.
Krajnak, K,
Dickenson L,
and
Lee TM.
The induction of Fos-like proteins in the suprachiasmatic nuclei and intergeniculate leaflet by light pulses in degus (Octodon degus) and rats.
J Biol Rhythms
12:
401-412,
1997.
14.
Kurumiya, S,
and
Kawamura H.
Circadian oscillation of the multiple unit activity in the guinea pig suprachiasmatic nucleus.
J Comp Physiol [A]
162:
301-308,
1988[Medline].
15.
Lu, J,
Shiromani P,
and
Saper CB.
Retinal input to the sleep-active ventrolateral preoptic nucleus in the rat.
Neuroscience
93:
209-219,
1999[ISI][Medline].
16.
Melander, T,
Hokfelt T,
and
Rokaeus A.
Distribution of galanin like immunoreactivity in the rat central nervous system.
J Comp Neurol
248:
475-517,
1986[ISI][Medline].
17.
Merchenthalter, I,
Lopez FJ,
and
Negro-Vilar A.
Anatomy and physiology of central galanin-containing pathways.
Prog Neurobiol
40:
711-769,
1993[ISI][Medline].
18.
Novak, CM,
and
Nunez AA.
A sparse projection from the suprachiasmatic nucleus to the sleep-active ventrolateral preoptic area in the rat.
NeuroReport
11:
93-96,
2000[ISI][Medline].
19.
Novak, CM,
and
Nunez AA.
Ventrolateral preoptic area and midline thalamic nuclei show daily rhythms in Fos activity.
Am J Physiol Regulatory Integrative Comp Physiol
275:
R1620-R1626,
1998
20.
Novak, CM,
Smale L,
and
Nunez AA.
Fos expression in the sleep-active cell group of the ventrolateral preoptic area in the diurnal murid rodent, Arvicanthis niloticus.
Brain Res
818:
375-382,
1999[ISI][Medline].
21.
Nunez, AA,
Bult A,
McElhinny TL,
and
Smale L.
Daily rhythms of Fos expression in hypothalamic targets of the suprachiasmatic nucleus in diurnal and nocturnal rodents.
J Biol Rhythms
14:
300-306,
1999[Abstract].
22.
Paxinos, G,
and
Watson C.
The Rat Brain in Stereotaxic Coordinates. San Diego: Academic, 1997.
23.
Peng, Z-C,
Grassi-Zucconi G,
and
Bentivoglio M.
Fos-related protein expression in the midline paraventricular nucleus of the rat thalamus: basal oscillation and relationship with limbic efferents.
Exp Brain Res
104:
21-29,
1995[ISI][Medline].
24.
Rusak, B,
Robertson HA,
Wisden W,
and
Hunt S.
Light pulses that shift rhythms induce gene expression in the suprachiasmatic nucleus.
Science
248:
1237-1240,
1990
25.
Salter, JM,
Sanders JT,
Haag M,
Smale L,
and
Cassone VM.
Diurnality, nocturnality, and 2-deoxyglucose uptake in the edible mouse, Arvicanthis niloticus.
Soc Neurosci Abstr
24 (12):
10,
1998.
26.
Sato, T,
and
Kawamura H.
Circadian rhythms in multiple unit activity inside and outside the suprachiasmatic nucleus in the diurnal chipmunk (Eutamais sibiricus).
Neurosci Res
1:
45-52,
1984[Medline].
27.
Sato, T,
and
Kawamura H.
Effects of bilateral suprachiasmatic nucleus lesions on the circadian rhythms in a diurnal rodent, the Siberian chipmunk (Eutamias sibiricus).
J Comp Physiol [A]
155:
745-752,
1984.
28.
Schwartz, J-C,
Arrang J-M,
Garbarg M,
Pollard H,
and
Ruat M.
Histaminergic transmission in the mammalian brain.
Physiol Rev
71:
1-51,
1991
29.
Schwartz, WJ,
Davidsen LC,
and
Smith CB.
In vivo metabolic activity of a putative circadian oscillator, the rat suprachiasmatic nucleus.
J Comp Neurol
189:
157-167,
1980[ISI][Medline].
30.
Schwartz, WJ,
Reppert SM,
Egan SM,
and
Moore-Ede MC.
In vivo metabolic activity of the suprachiasmatic nuclei: a comparative study.
Brain Res
274:
184-187,
1983[ISI][Medline].
31.
Senba, E,
Matsunaga K,
Tohyama M,
and
Noguchi K.
Stress-induced c-fos expression in the rat brain: activation mechanism of sympathetic pathway.
Brain Res Bull
31:
329-344,
1993[ISI][Medline].
32.
Sherin, JE,
Elmquist JK,
Torrealba F,
and
Saper CB.
Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat.
J Neurosci
18:
4701-4721,
1998.
33.
Sherin, JE,
Shiromani PJ,
McCarley RW,
and
Saper CB.
Activation of ventrolateral preoptic neurons during sleep.
Science
271:
216-219,
1996[Abstract].
34.
Silver, R,
LeSauter J,
Tresco PA,
and
Lehman MN.
A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian rhythms.
Nature
382:
810-813,
1996[Medline].
35.
Stevens, DR,
Kuramasu A,
and
Haas HL.
GABA-B-receptor-mediated control of GABAergic inhibition in rat histamine neurons in vitro.
Eur J Neurosci
11:
1148-1154,
1999[ISI][Medline].
36.
Szymusiak, R,
Alam N,
Steininger TL,
and
McGinty D.
Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats.
Brain Res
803:
178-188,
1998[ISI][Medline].
37.
Watts, AG,
and
Swanson LW.
Efferent projections of the suprachiasmatic nucleus: II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat.
J Comp Neurol
258:
230-252,
1987[ISI][Medline].
38.
Watts, AG,
Swanson LW,
and
Sanchez-Watts G.
Efferent projections of the suprachiasmatic nucleus: I. Studies using anterograde transport of Phaseolus vulgaris leucoagglutinin in the rat.
J Comp Neurol
258:
204-229,
1987[ISI][Medline].
39.
Yamazaki, S,
Kerbeshian MC,
Hocker CG,
Block GD,
and
Menaker M.
Rhythmic properties of the hamster suprachiasmatic nucleus in vivo.
J Neurosci
18:
10709-10723,
1998
This article has been cited by other articles:
![]() |
M. D. Schwartz and L. Smale Individual Differences in Rhythms of Behavioral Sleep and Its Neural Substrates in Nile Grass Rats J Biol Rhythms, December 1, 2005; 20(6): 526 - 537. [Abstract] [PDF] |
||||
![]() |
A. Salazar-Juarez, C. Escobar, and R. Aguilar-Roblero Anterior paraventricular thalamus modulates light-induced phase shifts in circadian rhythmicity in rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R897 - R904. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |